EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease

Zhicong Song iD, Shuai Bu, Suzhen Sang, Jie Li, Xihai Zhang, Xu Song, Yuqin Ran

Drug Design, Development and Therapy · 2025-04 · Volume 19 · 2693-2715

DOI: 10.2147/dddt.s514498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025-04. Verfasst von Zhicong Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Drugs, Chinese Herbal, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicine, Chinese TraditionalDrugs, Chinese HerbalNon-alcoholic Fatty Liver DiseaseFatty LiverHumansSignal TransductionAnimalsLipid Metabolism

Stichwörter der Autor:innen

action mechanismactive ingredientlipid metabolism disordermetabolic dysfunction-associated fatty liver diseasetraditional Chinese medicine

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
  • Department of Cardiology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
  • Affiliated Hospital of Shandong Academy of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.
  • Scientific Research Office, Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, People's Republic of China.

ORCID-Profile: Zhicong Song

Zitieren

APA

Song, Z., Bu, S., Sang, S., Li, J., Zhang, X., Song, X., & Ran, Y. (2025). The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease. Drug Design, Development and Therapy, Volume 19, 2693-2715. https://doi.org/10.2147/dddt.s514498

Vancouver

Song Z, Bu S, Sang S, Li J, Zhang X, Song X, et al. The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease. Drug Design, Development and Therapy. 2025;Volume 19:2693-2715. doi:10.2147/dddt.s514498

BibTeX
@article{Song2025,
  author = {Song, Zhicong and Bu, Shuai and Sang, Suzhen and Li, Jie and Zhang, Xihai and Song, Xu and Ran, Yuqin},
  title = {The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {2693--2715},
  doi = {10.2147/dddt.s514498}
}
Kostenlos starten →